Correlation Between GE Vernova and Celldex Therapeutics

Can any of the company-specific risk be diversified away by investing in both GE Vernova and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GE Vernova and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GE Vernova LLC and Celldex Therapeutics, you can compare the effects of market volatilities on GE Vernova and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GE Vernova with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GE Vernova and Celldex Therapeutics.

Diversification Opportunities for GE Vernova and Celldex Therapeutics

0.39

Correlation Coefficient

GE Vernova  Celldex Therapeutics

Weak diversification

The 3 months correlation between GEV and Celldex is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding GE Vernova LLC and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and GE Vernova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GE Vernova LLC are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of GE Vernova i.e., GE Vernova and Celldex Therapeutics go up and down completely randomly.

Pair Corralation between GE Vernova and Celldex Therapeutics

Considering the 90-day investment horizon GE Vernova LLC is expected to generate 1.1 times more return on investment than Celldex Therapeutics. However, GE Vernova is 1.1 times more volatile than Celldex Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Celldex Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  14,783  in GE Vernova LLC on February 23, 2024 and sell it today you would earn a total of  1,602  from holding GE Vernova LLC or generate 10.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

GE Vernova LLC  vs.  Celldex Therapeutics

GE Vernova LLC

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in GE Vernova LLC are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, GE Vernova showed solid returns over the last few months and may actually be approaching a breakup point.

Celldex Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Celldex Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Celldex Therapeutics may actually be approaching a critical reversion point that can send shares even higher in June 2024.

Pair Trading with GE Vernova and Celldex Therapeutics

The main advantage of trading using opposite GE Vernova and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GE Vernova position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.

The idea behind GE Vernova LLC and Celldex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.